Investors must take note of Allogene Therapeutics Inc’s (ALLO) performance last week, which was -4.10%.
Allogene Therapeutics Inc (NASDAQ: ALLO) on Tuesday, plunged -1.86% from the previous trading day, before settling in for the closing price of $4.29. Within the